AI assistant
Sending…
Medtronic plc — Director's Dealing 2019
Apr 2, 2019
29841_dirs_2019-04-02_1060d02d-ab5f-4489-98d5-f31384863d08.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-04-01
Reporting Person: OLEARY DENISE M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-04-01 | Ordinary Shares | M | 2671 | $29.96 | Acquired | 62484 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-04-01 | Stock Option (Right to Buy) | $29.96 | M | 2671 | Disposed | 2019-04-27 | Ordinary Shares (2671) | Direct |
Footnotes
F1: This balance increased by 547 shares due to exempt transactions such as dividend reinvestment.
F2: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
More from Medtronic plc
Report Publication Announcement
2026
Jun 3
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 18
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Interim / Quarterly Report
2026
Feb 24
Earnings Release
2026
Feb 17
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Jan 29